Core Scientific’s (CORZ) Buy Rating Reaffirmed at Needham & Company LLC

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. They currently have a $29.00 price target on the stock. Needham & Company LLC’s target price would indicate a potential upside of 46.72% from the stock’s previous close.

A number of other brokerages have also issued reports on CORZ. Freedom Capital upgraded shares of Core Scientific to a “hold” rating in a research report on Monday, June 15th. Sanford C. Bernstein restated an “outperform” rating and set a $32.00 price target on shares of Core Scientific in a research report on Wednesday, June 3rd. Lucid Cap Mkts upgraded Core Scientific to a “strong-buy” rating in a report on Friday, June 12th. Keefe, Bruyette & Woods lowered shares of Core Scientific from an “outperform” rating to a “market perform” rating and set a $25.00 target price for the company. in a research note on Monday. Finally, B. Riley Financial increased their price target on Core Scientific from $30.00 to $33.00 and gave the company a “buy” rating in a research report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.39.

Core Scientific Stock Down 4.7%

NASDAQ CORZ traded down $0.97 during trading hours on Tuesday, hitting $19.77. The company had a trading volume of 8,750,207 shares, compared to its average volume of 12,439,993. The business has a fifty day simple moving average of $25.36 and a 200-day simple moving average of $20.74. The firm has a market cap of $6.28 billion, a P/E ratio of -17.24 and a beta of 5.50. Core Scientific has a fifty-two week low of $12.60 and a fifty-two week high of $30.46.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The business had revenue of $115.24 million for the quarter, compared to the consensus estimate of $117.04 million. The company’s revenue for the quarter was up 44.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.25 EPS. Equities analysts forecast that Core Scientific will post 0.08 EPS for the current fiscal year.

Insider Activity

In related news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction on Monday, July 6th. The stock was sold at an average price of $22.63, for a total transaction of $226,300.00. Following the completion of the sale, the insider owned 2,023,426 shares of the company’s stock, valued at approximately $45,790,130.38. This trade represents a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last three months, insiders have sold 70,000 shares of company stock worth $1,802,400. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Core Scientific

Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Core Scientific by 18.7% during the fourth quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock worth $494,462,000 after buying an additional 5,359,710 shares during the last quarter. FNY Investment Advisers LLC bought a new position in Core Scientific during the fourth quarter valued at about $1,252,000. Nations Financial Group Inc. IA ADV acquired a new stake in shares of Core Scientific in the fourth quarter worth about $2,980,000. Jennison Associates LLC acquired a new stake in shares of Core Scientific in the fourth quarter worth about $14,075,000. Finally, Oasis Management Co Ltd. bought a new stake in shares of Core Scientific during the 4th quarter worth about $38,493,000.

Core Scientific News Roundup

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: AMD partnership strengthens AI growth outlook: Core Scientific agreed to provide AMD with access to up to 2.5 gigawatts of data-center capacity for AI deployments. The arrangement includes approximately 530 megawatts across five sites under 15-year agreements and could generate more than $14 billion in potential base contracted revenue. The companies will also collaborate on deploying AMD Instinct GPUs, EPYC CPUs and ROCm software. Core Scientific signs AI infrastructure deal with AMD
• Positive Sentiment: Adjusted earnings beat expectations: Zacks reported quarterly earnings of $0.18 per share, versus the consensus estimate of a $0.02 loss. The result also improved from a $0.04 loss per share a year earlier, suggesting better performance on an adjusted basis. Core Scientific surpasses Q2 earnings and revenue estimates
• Neutral Sentiment: Revenue increased: Core Scientific reported second-quarter revenue of $164.2 million. While the figure indicates continued scale, investors may focus more heavily on profitability and the timing of revenue from the new AI capacity agreements. Core Scientific Announces Second Quarter 2026 Results
• Negative Sentiment: Reported earnings were highly volatile: A separate earnings report showed a quarterly loss of $3.32 per share, creating a sharp contrast with the adjusted $0.18-per-share figure and potentially raising concerns about accounting adjustments, costs or non-cash items. Core Scientific quarterly earnings report
• Negative Sentiment: Analyst downgrade adds pressure: Keefe, Bruyette & Woods recently lowered Core Scientific from “outperform” to “market perform,” although it maintained a $25 price target. The downgrade signals reduced near-term conviction despite the target implying potential upside. Analyst rating information

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.